• Gefitinib (ZD1839): Selective EGFR Inhibitor in Advanced ...

  2025-10-05

  Gefitinib (ZD1839) empowers cancer researchers to dissect EGFR signaling and drug resistance in physiologically relevant assembloid models. By enabling robust apoptosis induction and G1 arrest, it accelerates translational workflows for personalized therapy discovery.

• TG003: A Selective Clk1 Inhibitor for Splice Site and Can...

  2025-10-04

  TG003 stands out as a potent and selective Cdc2-like kinase inhibitor, enabling precise modulation of alternative splicing and exon-skipping therapy. Its robust performance in both cellular and in vivo models makes it an indispensable tool for research in cancer resistance mechanisms, neuromuscular diseases, and RNA processing.

• Rucaparib (AG-014699): Precision PARP1 Inhibitor for DNA ...

  2025-10-03

  Rucaparib (AG-014699, PF-01367338) stands apart as a potent PARP1 inhibitor, enabling advanced radiosensitization and DNA damage response workflows in cancer biology research. Its unique efficacy in PTEN-deficient and ETS fusion-expressing models, along with data-driven protocol enhancements, empowers researchers to probe the intersection of DNA repair and regulated cell death.

• Genotyping Kit for Target Alleles: Advancing Contaminatio...

  2025-10-02

  Discover how the Genotyping Kit for target alleles of insects, tissues, fishes and cells empowers molecular biology genotyping research with rapid, single-tube DNA extraction and PCR amplification—enabling precise, contamination-resistant workflows across species. Explore the scientific mechanisms, cross-species applications, and future directions that set this rapid genomic DNA preparation kit apart.

• Spermine in Polyamine Signaling: Advanced Insights for Io...

  2025-10-01

  Explore the multifaceted roles of spermine, a key endogenous polyamine, in cell growth, protein synthesis, and ion channel regulation. This article delivers advanced scientific analysis and unique perspectives for researchers specializing in cellular metabolism and neurophysiology.

• Streptavidin-FITC: Precision Fluorescent Detection in Bio...

  2025-09-30

  Streptavidin-FITC elevates the sensitivity and flexibility of fluorescent detection in biotinylated molecule assays, from high-resolution intracellular trafficking to advanced flow cytometry. Its tetrameric structure and stable fluorescein isothiocyanate labeling enable robust, quantitative, and reproducible results even in challenging applications.

• NHS-Biotin: Enabling Precision Biotinylation in Multimeri...

  2025-09-29

  Explore how NHS-Biotin, a premier amine-reactive biotinylation reagent, underpins next-generation strategies for stable protein multimerization and advanced intracellular labeling. This article uniquely examines the interplay between NHS-Biotin chemistry, peptidisc-assisted nanobody clustering, and emerging applications in protein engineering.

• Trametinib (GSK1120212): MEK1/2 Inhibition as a Precision...

  2025-09-28

  Explore how Trametinib (GSK1120212), a potent MEK1/2 inhibitor, uniquely enables advanced MAPK/ERK pathway inhibition and targeted TERT regulation in cancer research. This in-depth analysis reveals novel experimental strategies distinct from existing approaches.

• Plerixafor (AMD3100): Mechanistic Insights and Innovation...

  2025-09-27

  Explore the advanced science behind Plerixafor (AMD3100), a leading CXCR4 chemokine receptor antagonist, with a unique focus on mechanistic dissection and translational innovations in hematopoietic stem cell and neutrophil mobilization. Uncover perspectives and technical depth not found in conventional cancer research reviews.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition for Cancer...

  2025-09-26

  Discover how BGJ398, a selective small molecule FGFR inhibitor, empowers advanced cancer research by dissecting FGFR-driven malignancies and cell signaling. This article uniquely explores translational insights and practical methodologies for leveraging BGJ398 in oncology and developmental biology.

• Influenza Hemagglutinin (HA) Peptide: Elevating Precision...

  2025-09-25

  Uncover the advanced scientific principles behind Influenza Hemagglutinin (HA) Peptide as a protein purification tag. This article uniquely explores its mechanistic utility in translational cancer research and competitive immunoprecipitation, offering expert insights not found in standard HA tag peptide guides.

• Biotin-16-UTP: Next-Generation RNA Labeling for Functiona...

  2025-09-24

  Biotin-16-UTP, a powerful biotin-labeled uridine triphosphate, revolutionizes in vitro transcription RNA labeling for advanced RNA detection and purification. Discover how this modified nucleotide enables high-resolution mapping of lncRNA-protein interactions, addressing critical mechanistic questions in molecular biology.

• Sulfo-Cy7 NHS Ester: Precision Protein Labeling for Advan...

  2025-09-23

  Explore how Sulfo-Cy7 NHS Ester, a sulfonated near-infrared fluorescent dye, enables precise amino group labeling for high-sensitivity imaging in complex biological systems. This article provides a rigorous perspective on optimizing protein and peptide labeling for mechanistic and translational bioimaging applications.

• Aurora kinases are a conserved family of serine threonine ki

  2025-04-22

  

  Aurora kinases are a conserved family of serine/threonine kinases that are important for the transition through mitosis and amplification and overexpression of Aurora kinases have been implicated in Cell Counting Kit-8 (CCK-8) and transformation. Aurora B is located at the centromere and controls a

• Demonstration of in vivo efficacy of

  2025-04-19

  

  Demonstration of in vivo efficacy of potential chemopreventive agents in animal models is necessary for their clinical development. Our present study provides experimental evidence that CuB 0.1μmol by oral administration (for 2weeks before the cancer cell injection, 5days per week) significantly inh

16348 records 8/1090 page Previous Next First page 上5页 678910 下5页 Last page